Risk Stratification of Early Breast Cancer (HR +/HER 2–) by CanAssist Breast and Its Corelation with Other Online Prognostic Tools: Experience from a Single Center

Risk Stratification of Early Breast Cancer (HR +/HER 2–) by CanAssist Breast and Its Corelation with Other Online Prognostic Tools: Experience from a Single Center

Introduction Risk assessment by various methods for HR +/HER2– early-stage breast cancer (EBC) patients help clinicians stratify risk and tailor individual treatment. Multiple prognostic tests are available, both free and expensive. Free prognostic tools, the Nottingham Prognostic Index (...

Full description

Saved in:
Bibliographic Details
Main Authors: Ajay Bapna, Sanjeev Patni, Nidhi Patni, Anil Kumar Gupta, Aseem Kumar Samar, Naresh Ledwani, Tarachand Gupta, Pawan Agarwal
Format: Article
Language:English
Published: Thieme Medical and Scientific Publishers Pvt. Ltd.
Series:Indian Journal of Medical and Paediatric Oncology
Subjects:
breast cancer
prognosis
CanAssist Breast
Nottingham Prognostic Index
modified Adjuvant
hormone receptor-positive
early-stage breast cancer
Online Access:http://www.thieme-connect.de/DOI/DOI?10.1055/s-0043-1771404
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Introduction Risk assessment by various methods for HR +/HER2– early-stage breast cancer (EBC) patients help clinicians stratify risk and tailor individual treatment. Multiple prognostic tests are available, both free and expensive. Free prognostic tools, the Nottingham Prognostic Index (NPI), and modified Adjuvant Online (mAOL) rely on clinical parameters. CanAssist Breast (CAB) considers both clinical parameters and tumor biology for assessing the risk of recurrence.
ISSN:0971-5851
0975-2129

Similar Items